Havana, Apr 6 (Press) President Miguel Díaz-Canel described the impact of Cuban vaccines against Covid-19 as unstoppable and welcomed the fact that one of them, Abdala, has a file ready to be endorsed internationally.
The president thus reacted to the announcement that the scientific documentation regarding Abdala’s results, with which millions of Cubans have been immunized, is ready to be analyzed by specialists from the Pan American (PAHO) and World Health Organizations (WHO). .
This is excellent news: the Abdala vaccine file is ready to be reviewed by PAHO experts, the head of state signed on his Twitter account.
He added that the impact of the vaccines on the Antillean island “is undeniable and unstoppable. The best example of the creative resistance of this town”, he pointed out.
Abdala will be a pioneer in the largest of the Antilles in presenting her dossier to the WHO and initiating the process of international recognition.
Led by the Center for Genetic Engineering and Biotechnology (CIGB), formal exchanges with the WHO on this immunogen began in March.
The Group of Biotechnological and Pharmaceutical Industries (BioCubaFarma) detailed on its Twitter account that the United Nations organization has already been informed about the completed document to be sent to the experts.
In the middle of last February, the director of BioCubaFarma, Eduardo Martínez, explained that the company was working on the text, made up of several chapters with results on clinical and preclinical research, pharmaceutical development and everything associated with production facilities, an aspect that adaptations were made.
Regarding the processes that Abdala had followed for this evaluation, Martínez pointed out that the decision was made to change the production site for the recently inaugurated plant in the Mariel Special Development Zone, located in that industrial pole west of Havana.
In operation since November 2021, the CIGB-Mariel Technological Industrial is considered the most modern in Cuba and one of the most advanced in Latin America and the Caribbean.
It has laboratories for quality control, warehouses for raw materials and final products, plants to obtain the active ingredient of vaccines and complete immunogens in liquid, powder and spray formulations.
The objective is that the representatives of the WHO also visit the productive plants of that entity where they will carry out the necessary inspection to later obtain the permit and its inclusion in the list of products recognized by the organization, Martínez stressed.
Cuba administered more than 35 million doses of its own vaccines against Covid-19: Soberana 02, Soberana Plus (both from the Finlay Institute of Vaccines) and Abdala, according to data from the Ministry of Public Health.